NASDAQ:ATRA
$1.77
(
-7.81%
)
Friday, 26th May 2023
Atara Biotherapeutics Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $1.75 | $3.02 | Friday, 26th May 2023 ATRA stock ended at $1.77. This is 7.81% less than the trading day before Thursday, 25th May 2023. During the day the stock fluctuated 10.29% from a day low at $1.75 to a day high of $1.93. |
| 90 days | $1.75 | $4.21 | |
| 52 weeks | $1.75 | $9.34 |
Historical Atara Biotherapeutics prices
| Date | Open | High | Low | Close | Volume |
| 2023-05-26 | $1.77 | $1.93 | $1.75 | $1.77 | 1 851 174 |
| 2023-05-25 | $1.92 | $1.94 | $1.84 | $1.92 | 1 307 520 |
| 2023-05-24 | $2.08 | $2.08 | $1.87 | $1.92 | 2 171 400 |
| 2023-05-23 | $2.08 | $2.29 | $2.08 | $2.08 | 1 371 766 |
| 2023-05-22 | $2.12 | $2.19 | $2.05 | $2.10 | 1 579 487 |
| 2023-05-19 | $2.08 | $2.20 | $2.08 | $2.11 | 1 451 168 |
| 2023-05-18 | $2.05 | $2.14 | $1.94 | $2.04 | 1 975 916 |
| 2023-05-17 | $2.07 | $2.07 | $1.97 | $2.06 | 1 818 565 |
| 2023-05-16 | $2.12 | $2.16 | $1.95 | $2.08 | 1 704 031 |
| 2023-05-15 | $2.14 | $2.31 | $2.14 | $2.20 | 1 972 917 |
| 2023-05-12 | $2.33 | $2.35 | $2.10 | $2.14 | 2 464 906 |
| 2023-05-11 | $2.39 | $2.44 | $2.27 | $2.30 | 1 735 042 |
| 2023-05-10 | $2.47 | $2.47 | $2.21 | $2.43 | 2 062 993 |
| 2023-05-09 | $2.86 | $2.90 | $2.19 | $2.44 | 3 272 337 |
| 2023-05-08 | $2.91 | $3.02 | $2.86 | $2.97 | 714 511 |
| 2023-05-05 | $2.78 | $2.97 | $2.75 | $2.91 | 970 392 |
| 2023-05-04 | $2.67 | $2.78 | $2.55 | $2.75 | 1 847 521 |
| 2023-05-03 | $2.59 | $2.76 | $2.56 | $2.70 | 1 571 269 |
| 2023-05-02 | $2.81 | $2.81 | $2.43 | $2.58 | 2 484 135 |
| 2023-05-01 | $2.70 | $2.86 | $2.66 | $2.81 | 949 447 |
| 2023-04-28 | $2.57 | $2.82 | $2.46 | $2.71 | 1 177 816 |
| 2023-04-27 | $2.76 | $2.74 | $2.56 | $2.58 | 1 194 512 |
| 2023-04-26 | $2.87 | $2.89 | $2.68 | $2.73 | 749 650 |
| 2023-04-25 | $2.90 | $2.99 | $2.85 | $2.86 | 1 050 634 |
| 2023-04-24 | $3.00 | $3.01 | $2.86 | $2.94 | 1 199 544 |
| 2023-04-21 | $2.84 | $3.06 | $2.83 | $3.04 | 1 055 576 |
| 2023-04-20 | $2.94 | $2.95 | $2.80 | $2.84 | 1 811 974 |
| 2023-04-19 | $2.90 | $3.05 | $2.85 | $2.98 | 1 177 877 |
| 2023-04-18 | $3.06 | $3.08 | $2.92 | $2.96 | 1 309 846 |
| 2023-04-17 | $2.70 | $3.04 | $2.67 | $3.03 | 1 334 469 |
| 2023-04-14 | $2.61 | $2.76 | $2.58 | $2.69 | 1 090 811 |
| 2023-04-13 | $2.37 | $2.73 | $2.34 | $2.71 | 1 308 863 |
| 2023-04-12 | $2.61 | $2.62 | $2.32 | $2.36 | 1 776 678 |
| 2023-04-11 | $2.74 | $2.78 | $2.59 | $2.59 | 985 111 |
| 2023-04-10 | $2.75 | $2.76 | $2.63 | $2.73 | 1 113 255 |
| 2023-04-06 | $2.81 | $2.82 | $2.71 | $2.77 | 919 991 |
| 2023-04-05 | $2.83 | $2.86 | $2.73 | $2.78 | 957 648 |
| 2023-04-04 | $2.97 | $2.97 | $2.79 | $2.85 | 1 762 853 |
| 2023-04-03 | $2.86 | $2.99 | $2.85 | $2.94 | 809 587 |
| 2023-03-31 | $2.85 | $2.93 | $2.81 | $2.90 | 854 115 |
| 2023-03-30 | $2.98 | $3.04 | $2.76 | $2.80 | 936 528 |
| 2023-03-29 | $2.96 | $3.00 | $2.86 | $2.98 | 811 395 |
| 2023-03-28 | $2.96 | $3.00 | $2.85 | $2.86 | 935 780 |
| 2023-03-27 | $2.89 | $3.03 | $2.84 | $2.97 | 908 166 |
| 2023-03-24 | $2.79 | $2.90 | $2.76 | $2.87 | 1 703 720 |
| 2023-03-23 | $2.92 | $2.97 | $2.77 | $2.86 | 1 122 587 |
| 2023-03-22 | $3.01 | $3.02 | $2.84 | $2.87 | 2 819 516 |
| 2023-03-21 | $3.02 | $3.17 | $3.00 | $3.02 | 2 026 295 |
| 2023-03-20 | $3.02 | $3.02 | $2.82 | $2.98 | 1 317 054 |
| 2023-03-17 | $3.06 | $3.08 | $2.92 | $3.02 | 3 585 443 |
About Atara Biotherapeutics
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as hematologic and solid tumors, including nasopharyngeal carcinoma. The company i... ATRA Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
